Extinction of Tumor Antigen Expression by SF2/ASF in JCV-Transformed Cells

Elena Uleri1, Sarah Beltrami, Jennifer Gordon

  • 1Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA.

Genes & Cancer
|December 31, 2011
PubMed

Insights

The splicing factor SF2/ASF suppresses JC virus (JCV) oncogene expression, inhibiting tumor growth. Downregulation of SF2/ASF promotes proliferation in JCV-transformed cells, revealing its tumor suppressor role.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Human neurotropic polyomavirus JC (JCV) is linked to neural-origin tumors, including medulloblastomas and glioblastomas.
  • JCV's oncogenic activity stems from its early gene products, large T and small t antigens.
  • The splicing factor SF2/ASF was previously shown to negatively regulate JCV gene transcription and splicing in glial cells.

Purpose of the Study:

  • To investigate the role of SF2/ASF in JCV-mediated cellular transformation and tumor development.
  • To determine if SF2/ASF expression affects the oncogenic activity of JCV tumor antigens.
  • To identify the functional domain of SF2/ASF responsible for its tumor suppressor activity.

Main Methods:

  • Assessing SF2/ASF's effect on large T antigen expression in JCV-transformed tumor cell lines.
  • Evaluating the impact of SF2/ASF expression levels on tumor cell proliferation and transformation.
  • Performing mapping analysis to identify the minimal peptide domain of SF2/ASF involved in JCV promoter silencing and tumor suppression.

Main Results:

  • SF2/ASF directly suppresses large T antigen expression in JCV-transformed tumor cells, thereby inhibiting their transforming capacity.
  • Down-regulation of SF2/ASF in these cells leads to increased tumor cell growth and proliferation.
  • Amino acid residues 76 to 100 of SF2/ASF were identified as the minimal functional domain for suppressing tumor cell growth.

Conclusions:

  • SF2/ASF acts as a tumor suppressor by inhibiting JCV's oncogenic activity.
  • SF2/ASF plays a critical role in regulating JCV-mediated cellular transformation.
  • These findings offer new insights into the pathogenic mechanisms of JCV-induced tumors and potential therapeutic targets.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...